Symbol

DARE Stock Financials and Fundamentals

Company Info

Company Full Name

Dare Bioscience, Inc.

Full name of the company.

Industry Name

MEDICAL-BIOMED/GENETICS

Industry name

Major Industry Name

DRUGS

Major industry name

Sector Name

Medical

Sector name

Market Info

Current Price

$2.12

Current price of the stock

Trading Volume

$154K

Trading volume of the stock

Market Capitalization

$18.8M

Market capitalization of the company

Market Cap Category

Nano Cap

Category of market capitalization

Long-Term Growth Estimate

Long-term growth mean estimate

Analyst Rating Mean

4.60

Mean analyst rating

Potential Upside

407.08%

Potential price appreciation based on analyst price targets

EPS Surprise Percentage Difference

18.18%

Percentage difference of EPS surprise

Dividends

Dividend Change (1 Year)

Dividend change over 1 year

Dividend Rate

$0.00

Shows the amount of dividend paid

Balance Sheet

Total Debt to Equity Ratio

-0.16

Total debt to total equity ratio

Current Ratio

0.34

Current ratio

Company Profitability

Gross Profit Margin

100.00%

Gross profit margin

Operating Profit Margin

18079.54%

Operating profit margin

EBIT Margin

18079.54%

Earnings before interest and taxes (EBIT) margin

EBITDA Margin

Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin

Pretax Profit Margin

18970.73%

Pretax profit margin

Net Profit Margin

18970.73%

Net profit margin

Return on Equity (ROE)

31.54%

Measures profitability relative to shareholders' equity

Return on Tangible Equity

31.54%

ROE excluding intangible assets

Return on Assets (ROA)

-30.94%

Measures profitability relative to total assets

Return on Invested Capital (ROIC)

31.96%

Measures profitability relative to invested capital

Management Effectiveness

Asset Turnover (quarterly)

-0.00

Asset turnover ratio

Inventory Turnover (quarterly)

Inventory turnover ratio

Receivables Turnover (quarterly)

-0.11

Receivables turnover ratio

Days Sales Outstanding

-799.66

Average number of days it takes to collect receivables

Valuation Measures

Price-to-Earnings (P/E) Ratio

-0.99

Measures valuation relative to earnings

Forward P/E Ratio

P/E based on future earnings estimates

Price-to-Sales (P/S) Ratio

-1062.52

Measures valuation relative to sales

Price-to-Book (P/B) Ratio

-1.50

Measures valuation relative to book value

Price-to-Operating Cash Flow (P/OCF) Ratio

-1.77

Measures valuation relative to operating cash flow

Price-to-Free Cash Flow (P/FCF) Ratio

-1.65

Measures valuation relative to free cash flow

Cash Flow Statement

Net Acquisitions/Divestitures

Indicates company's M&A activity